Sasanlimab
B8011006
Phase 3 small_molecule active
Quick answer
Sasanlimab for Non-Muscle Invasive Bladder Cancer is a Phase 3 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Non-Muscle Invasive Bladder Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active